Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


       2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Lansaprazole

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Lansaprazole Manufacturers in India Suppliers Lansaprazole Exporters Distributors Lansaprazole api active pharmaceuticals ingredients Lansaprazole manufacturers Side Effects bulk drugs raw material Lansaprazole companies Side Effects Importers Lansaprazole Lansaprazole Exporters Lansaprazole exporters FDA Lansaprazole DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Lansaprazole manufacturing pharmaceutical drugs pharmaceutical intermediates Lansaprazole pharmaceutical chemicals pharmaceutical raw materials Lansaprazole active pharmaceutical ingredients Lansaprazole committee active pharmaceutical ingredients manufacturer Lansaprazole Active Pharmaceutical Ingredients manufacturer Lansaprazole exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Lansaprazole, Lansaprazole manufacturer India, Lansaprazole product, Lansaprazole products, Api preparation, Certificate of Analysis API manufacturer product, Lansaprazole anti ulcer product, Certificate of Origin COA Lansaprazole COS Lansaprazole, pharmaceutical generic, pharmaceutical drug, medical, Lansaprazole pharma healthcare, pharma patents, contract MSDS manufacturing Trader Lansaprazole pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Lansaprazole expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Lansaprazole DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Lansaprazole ingredients, api, HIV Lansaprazole, tablets, capsules, syrup & protein Lansaprazole powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Lansaprazole gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Lansaprazole WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List >>
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

 calcium channel
 

Lansoprazole Lansoprazole

Lansoprazole Lansoprazole

Lansoprazole Lansoprazole

 

 

 

HOME >> Pharmaceuticals API List 2 >> Lansaprazole

Lansaprazole Cas No. 103577-45-3

The active ingredient in Lansoprazole Delayed-Release Capsules

Lansaprazole Cas No. 103577-45-3
pdf api

The active ingredient in Lansoprazole Delayed-Release Capsules, Lansoprazole for Delayed-Release Oral Suspension and Lansoprazole SoluTab Delayed- Release Orally Disintegrating Tablets is lansoprazole, a substituted benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl] methyl] sulfinyl] benzimidazole, a compound that inhibits gastric acid secretion. Its empirical.

Lansoprazole is a white to brownish-white odorless crystalline powder which melts with decomposition at approximately 166C. Lansoprazole is freely soluble in dimethylformamide; soluble in methanol; sparingly soluble in ethanol; slightly soluble in ethyl acetate, dichloromethane and acetonitrile; very slightly soluble in ether; and practically insoluble in hexane and water.

Lansoprazole is stable when exposed to light for up to two months. The rate of degradation of the compound in aqueous solution increases with decreasing pH. The degradation half-life of the drug substance in aqueous solution at 25C is 18 hours at pH 7.0.

Lansoprazole is supplied in delayed-release capsules, in delayed-release orally disintegrating tablets for oral administration and in a packet for delayed-release oral suspension.

The delayed-release capsules are available in two dosage strengths: 15 mg and 30 mg of lansoprazole per capsule. Each delayed-release capsule contains enteric-coated granules consisting of 15 mg or 30 mg of lansoprazole (active ingredient) and the following inactive ingredients: hydroxypropyl cellulose, low substituted hydroxypropyl cellulose, colloidal silicon dioxide, magnesium carbonate, methacrylic acid copolymer, starch, talc, sugar sphere, sucrose, polyethylene glycol, polysorbate 80, and titanium dioxide. Lansoprazole SoluTab Delayed-Release Orally Disintegrating Tablets are available in two dosage strengths: 15 mg and 30 mg of lansoprazole per tablet. Each delayed-release orally disintegrating tablet contains enteric-coated microgranules consisting of 15 mg or 30 mg of lansoprazole (active ingredient) and the following inactive ingredients: lactose monohydrate, microcrystalline cellulose, magnesium carbonate, hydroxypropyl cellulose, hypromellose, titanium dioxide, talc, mannitol, methacrylic acid, polyacrylate, polyethylene glycol, glyceryl monostearate, polysorbate 80, triethyl citrate, ferric oxide, citric acid, crospovidone, aspartame **, artificial strawberry flavor and magnesium stearate. Lansoprazole for Delayed-Release Oral Suspension are available in two dosage strengths: 15 mg and 30 mg of lansoprazole per packet. Each packet of delayed-release oral suspension contains enteric-coated granules consisting of 15 or 30 mg of lansoprazole (active ingredient) and the following inactive ingredients (inactive granules): confectioner's sugar, mannitol, docusate sodium, crospovidone, citric acid, sodium citrate, magnesium stearate, and artificial strawberry flavor. The lansoprazole granules and inactive granules, present in unit dose packets, are constituted with water to form a suspension and consumed orally.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE
SIDE EFFECTS
PRECAUTIONS
INTERACTION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj pharmaceuticals API Logo

Lansoprazole

More Api at Taj Pharmaceuticals Ltd.

Lacidipine

Lamotrigine

Lansoprazole

Levetiracetam

Levo Cetirizine

Levofloxacin

Loratadine

Losartan Potassium

Metoprolol Succinate

Montelukast Sodium

Moxifloxacin HCl

Naproxen

Naratriptan

Norfloxacin

Nizatidine

Olmesartan

Omeprazole

Omeprazole Sodium

Oxaprozin

Paroxetine

Pantoprazole

Primidone

Copyright Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited  products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.